Dropscreen, ViewAllergy39 not equally effective for detecting allergens, study finds

New survey data from the Orlando Health Spine Center reveals a significant difference among Americans on how to manage neck and back pain. Respondents were split between relying on rest and reduced activity (44%), turning to over-the-counter pain relievers (42%), and hot/cold therapies (29%)—an uncertainty that may be discouraging some from seeking medical guidance.

A study presented at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting found that almost half of gunshot wound injuries to the brain in children and young adults include penetrating cerebrovascular injuries (PCVIs).

In a remarkable achievement that is already impacting how we detect and diagnose disease, UK Biobank has completed the world's largest whole body imaging project, scanning the brains, hearts, abdomens, blood vessels, bones and joints of 100,000 volunteers. These scans, on this scale, show us what is happening in people's bodies as they age so we can understand how, why and when we get sick.

A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a study presented at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.

Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB), shows potential as a new treatment approach for two leading causes of blindness worldwide.

In a study published in Cell on July 10, researchers reported the first comprehensive study of whole-brain projectomes of the macaque prefrontal cortex (PFC) at the single-neuron level and revealed the organization of macaque PFC connectivity.

Adrenal hormone function was restored in animal studies, potentially paving the way for a functional cure for primary adrenal insufficiency in humans, according to research presented by Aspect Biosystems at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.

Stroke is said to be the second leading cause of death worldwide after heart disease. To prevent the death of neurons in the brain, a research group led by Osaka Metropolitan University Associate Professor Hidemitsu Nakajima of the Graduate School of Veterinary Science has developed a drug that inhibits a protein involved in cell death.

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, according to a study presented at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.

Researchers from the University of Adelaide are hopeful a recent biological discovery could lead to the precision treatment of bipolar disorder (BD).

Hyperbaric oxygen therapy (HBOT) used in conjunction with corticosteroids aids outcomes for sudden sensorineural hearing loss (SSNHL), according to a study published online in Clinical Otolaryngology.

University of Leeds psychologists report that stress appraisal and perceived stress act as key conduits linking childhood trauma to adult depression, anxiety, defeat, and entrapment.

Obesity and type 2 diabetes in adolescence can interfere with bone development, potentially increasing the risk of fractures and osteoporosis later in life, according to a study presented at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.

A new study led by Children's Hospital Los Angeles has found a novel mechanism behind neuroblastoma progression: the shape and structure of the extracellular matrix.

A study led by Prof. Liang Xingjie's team from the National Center for Nanoscience and Technology of the Chinese Academy of Sciences (CAS) reported a biomimetic physical barrier (BPB) that temporarily blocks T cell-tumor cell interactions, effectively delaying T cell exhaustion and enabling a stronger, more sustained immune response, which represents a step forward for improving cancer immunotherapy outcomes.

A population-based study led by the University of Turku, Finland, investigated factors associated with the prevalence of antibiotic resistance. In addition to antibiotic use, diet, gender, living environment, income level and certain gut bacteria were associated with a higher burden of resistance. A higher resistance burden was associated with a 40% higher risk of all-cause mortality during the follow-up.

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and hemophilia.

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.